Ylenia Perone
Titolo
Citata da
Citata da
Anno
Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation
RS Auriemma, Y Perone, A Di Sarno, LFS Grasso, E Guerra, M Gasperi, ...
The Journal of Clinical Endocrinology & Metabolism 98 (1), 372-379, 2013
762013
Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas
RS Auriemma, R Pivonello, Y Perone, LF Grasso, L Ferreri, C Simeoli, ...
Eur J Endocrinol 169 (3), 359-366, 2013
562013
Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer
L Magnani, G Frige, RM Gadaleta, G Corleone, S Fabris, H Kempe, ...
Nature genetics 49 (3), 444-450, 2017
482017
Effect of cabergoline on metabolism in prolactinomas
RS Auriemma, L Granieri, M Galdiero, C Simeoli, Y Perone, P Vitale, ...
Neuroendocrinology 98 (4), 299-310, 2013
462013
Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer
DK Patten, G Corleone, B Győrffy, Y Perone, N Slaven, I Barozzi, E Erdős, ...
Nature medicine 24 (9), 1469-1480, 2018
372018
Treatment with GH receptor antagonist in acromegaly: effect on cardiac arrhythmias
RS Auriemma, R Pivonello, MC De Martino, G Cudemo, LF Grasso, ...
Eur J Endocrinol 168 (1), 15-22, 2013
272013
Pregnancy and tumor outcomes in women with prolactinoma
B Araujo, S Belo, D Carvalho
Experimental and Clinical Endocrinology & Diabetes 125 (10), 642-648, 2017
132017
Hyperprolactinemia and the association with all-cause mortality and cardiovascular mortality
J Krogh, C Selmer, C Torp-Pedersen, GH Gislason, C Kistorp
Hormone and Metabolic Research 49 (06), 411-417, 2017
112017
SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer
Y Perone, AJ Farrugia, A Rodríguez-Meira, B Győrffy, C Ion, A Uggetti, ...
Nature communications 10 (1), 1-15, 2019
102019
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
L Butler, Y Perone, J Dehairs, LE Lupien, V de Laat, A Talebi, M Loda, ...
Advanced drug delivery reviews, 2020
62020
Author Correction: SREBP1 drives keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer
Y Perone, AJ Farrugia, A Rodríguez-Meira, B Győrffy, C Ion, A Uggetti, ...
Nature communications 10 (1), 1-1, 2019
12019
Journal club: epigenetic profiling to classify cancer of unknown primary
Y Perone, FM Fioretti
The Lancet Oncology 18 (3), e130, 2017
12017
Going off the grid: ERα breast cancer beyond estradiol
Y Perone, L Magnani
Endocrinology 57, F1-F5, 2016
12016
Abstract P4-07-06: Breast cancer subtype classification using NanoString and RNAseq technologies
A Rocca, S Ravaioli, E Fonzi, I Barozzi, Y Perone, L Magnani, F Pirini, ...
Cancer Research 80 (4 Supplement), P4-07-06-P4-07-06, 2020
2020
OR34-2 SREBP1 Drives KRT80-Dependent Cytoskeletal Changes and Invasive Behaviour in Endocrine-Resistant ERα Breast Cancer
Y Perone, A Rodríguez Meira, A Farruggia, B Győrffy, C Ion, G Pruneri, ...
Journal of the Endocrine Society 3 (Supplement_1), OR34-2, 2019
2019
PO-357 SREBP1 drives cell-autonomous cytoskeletal changes by KRT80 remodelling during ERα breast cancer progression
Y Perone, AR Meira, A Farruggia, B Győrffy, C Ion, G Pruneri, A Lim, ...
ESMO Open 3 (Suppl 2), A161-A162, 2018
2018
PO-355 Enhancers mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer
L Magnani, D Patten, G Corleone, Y Perone, N Slaven, I Barozzi, ...
ESMO Open 3 (Suppl 2), A161-A161, 2018
2018
SREBP1 drives KRT80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer
L Magnani, Y Perone, A Farrugia, A Meira, B Gyorffy, C Ion, A Uggetti, ...
bioRxiv, 380634, 2018
2018
Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ER alpha metastatic breast cancer (vol 49, pg 444, 2017)
L Magnani, G Frige, RM Gadaleta, G Corleone, S Fabris, MH Kempe, ...
NATURE GENETICS 49 (6), 970-970, 2017
2017
Effects of short (12 months) and long (60 months) term treatment with cabergoline on metabolic syndrome and visceral adiposity index in patients with hyperprolactinemia
RS Auriemma, L Granieri, Y Perone, M Galdiero, L Grasso, C Simeoli, ...
15th European Congress of Endocrinology 32, 2013
2013
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20